Cellular lipid bilayers and systemic lipid metabolic pathways

Cellular lipid bilayers and systemic lipid metabolic pathways represent the structural and biochemical framework governing lipid homeostasis in the body. Lipid bilayers are semi-permeable membranes composed primarily of phospholipids and cholesterol that define cellular boundaries and host essential signaling proteins (Alberts B, et al., Molecular Biology of the Cell, 2002). Systemic lipid metabolic pathways encompass the complex processes of lipid ingestion, synthesis, transport, and degradation, which are critical for energy production and cellular signaling (StatPearls, Lipid Metabolism, 2023). While not a single molecular target, these systems are the focus of numerous therapeutic interventions aimed at managing cardiovascular and metabolic diseases. Drugs like statins target specific enzymes within these pathways, such as HMG-CoA reductase, to lower circulating cholesterol levels (PubChem, Atorvastatin). Additionally, certain antimicrobial agents like amphotericin B act by directly binding to and disrupting the integrity of microbial lipid bilayers (PubMed, PMID: 25118115). Dysregulation of these pathways is a primary driver of atherosclerosis, obesity, and metabolic syndrome (NIH, NHLBI). Understanding the interplay between membrane structure and metabolic flux is essential for developing next-generation therapies for metabolic disorders.

Other names

Biological membranesLipid metabolismLipidomePlasma membraneLipid homeostasis

Pharmacological intervention involves the inhibition of rate-limiting enzymes in lipid synthesis (e.g., HMG-CoA reductase), the modulation of lipid transport proteins (e.g., NPC1L1), the activation of nuclear receptors (e.g., PPAR-alpha), or the direct physical disruption of membrane integrity in pathogens.